What Is Filgrastim and What Does It Do?
Filgrastim — the active ingredient in Zarzio — is a laboratory-produced version of a protein your body makes naturally called granulocyte-colony stimulating factor (G-CSF). This protein plays a critical role in telling your bone marrow to produce more neutrophils, the white blood cells most responsible for fighting bacterial and fungal infections.
When cancer treatments like chemotherapy damage rapidly dividing cells, they don't only target tumour cells — they also affect the bone marrow, where blood cells are made. This can cause neutrophil counts to drop dangerously low, a condition called neutropenia. Zarzio is prescribed to counteract this effect.
The Role of G-CSF in the Body
Under normal circumstances, your body produces G-CSF in small amounts to maintain a steady supply of neutrophils. When you develop an infection or your neutrophil count drops, G-CSF production naturally increases to trigger faster cell production. Filgrastim mimics and amplifies this natural process.
Specifically, filgrastim works by:
- Binding to G-CSF receptors on the surface of bone marrow stem cells and neutrophil precursors
- Stimulating proliferation — signalling precursor cells to divide and multiply
- Accelerating differentiation — encouraging immature cells to mature into functional neutrophils
- Promoting release — mobilising mature neutrophils from the bone marrow into the bloodstream
- Enhancing neutrophil function — improving the ability of existing neutrophils to seek out and destroy pathogens
From Injection to Immune Response: A Step-by-Step Overview
- Administration: Zarzio is injected subcutaneously (under the skin) or, in some clinical settings, intravenously.
- Absorption: The protein is absorbed into the bloodstream and travels to the bone marrow.
- Receptor binding: Filgrastim binds to G-CSF receptors on haematopoietic (blood-forming) stem cells.
- Signalling cascade: Receptor activation triggers intracellular signalling pathways (including JAK/STAT pathways) that switch on genes governing cell growth and survival.
- Neutrophil surge: Within 24–72 hours, measurable increases in circulating neutrophils are typically observed.
Why Does the Timing of Treatment Matter?
Zarzio is generally started 24 to 72 hours after a chemotherapy cycle ends. Starting too soon may actually harm rapidly dividing bone marrow cells still vulnerable to treatment effects. Your haematology or oncology team will determine the correct timing based on your specific treatment protocol.
What Are Neutrophils and Why Do They Matter?
Neutrophils are the most abundant type of white blood cell in healthy adults, making up around 50–70% of all circulating white cells. They form the first line of defence against bacterial and fungal invaders, engulfing and destroying pathogens through a process called phagocytosis. When neutrophil counts fall too low, even minor infections can become life-threatening — which is why restoring them quickly is a medical priority.
Key Takeaways
- Filgrastim is a biosynthetic version of naturally occurring G-CSF
- It works by binding to receptors in the bone marrow to trigger neutrophil production
- The effect is measurable within days of starting treatment
- Timing relative to chemotherapy is clinically important
- The goal is to shorten the period of dangerous neutropenia and reduce infection risk
This article is for educational purposes only. Always follow the guidance of your healthcare team regarding your specific treatment plan.